Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S24 pseudogene 18 is a processed pseudogene found in the human genome. It is among many pseudogenes derived from the ribosomal protein S24 gene, which encodes a structural protein of the 40S ribosomal subunit—a key component in cellular protein synthesis. Pseudogenes do not produce functional proteins but may occasionally play regulatory roles. There is no evidence of RPS24P18 having functional significance or acting as a drug target. Most research and clinical interest is on the parental RPS24 gene, whose mutations can cause Diamond-Blackfan anemia, not the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S24 pseudogene 18 (RPS24P18).